CSN Login
Members Online: 2

You are here

Announcements

Have an announcement? Complete and submit an announcement submission request form. Announcements are selected based on relevance and available space. Selection does not imply endorsement by the American Cancer Society.

Thursday, February 1, 2018 - 12:07am

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Friday, January 5, 2018 - 12:30pm

Hello! I am a PhD student in the School of Education at Walden University. I am completing a study that describes the self-learning experiences of women who use Facebook to learn about their breast cancer and how these experiences reflect the concepts of connectivism, a learning theory (Siemens, 2006). 


I am seeking 10 participants who are interested in describing their experiences using Facebook as a tool for learning about their breast cancer. You must meet the following criteria to be considered as a participant: 
1. A woman over the age of 21. 
2. A woman who had breast cancer or who is currently undergoing breast cancer treatment. 
3. A woman who is a member of a group or groups on Facebook dedicated to breast cancer, either in the past or currently.
4. A woman who identifies as using Facebook to learn about her disease.

Voluntary participation in this research includes participating in an audio recorded individual interview using a web conferencing tool, where I will ask you questions about your experiences related to learning about your breast cancer diagnosis. The initial interview will take approximately 60 minutes. I will send you a follow-up reflective questionnaire via a password protected site that will take approximately 30 minutes to complete. If you participate in the interview and the follow-up questionnaire, your total time commitment will be approximately 1.5 hours. I will keep all data confidential. 

How to Participate: 
If you would like to participate, please indicate your interest by completing the interest form found at this link. I will send consent forms to the first 10 individuals who respond to this inquiry and meet the criteria. 
If you have any questions about this study, please respond in the comment section of the form. 
Thank you!

https://app.smartsheet.com/b/form/e27f9dea189f4ef5957b1d8bcb3514db

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
KAREN WONDERGEM
6026703763
karen.wondergem@waldenu.edu
Friday, December 8, 2017 - 12:44pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Thursday, December 7, 2017 - 3:00pm

Dear Prostate Cancer Patients:

If you are gay or bisexual man, between the age of 18 and 75, and have been previously treated for prostate cancer, we would like to invite you to participate in our current research study.

Twenty minutes to one hour of your time may influence treatment of future patients.

There is a significant knowledge gap concerning sexual function for prostate cancer patients in the men who have sex with men (MSM) community, because all of the existing assessment tools are designed for the heterosexual population. The goal of this study is to develop a survey to assess sexual function after prostate cancer treatment specific for MSM. Increased knowledge in this area can help guide future patients in treatment decisions.

Your participation will involve completion of a set of questions online. Your response can help us refine this list and develop the survey. No personal information will be collected in the survey and all your response will be kept confidential. This study is being supported by the UBC British Columbia Cancer Agency Research Ethics Board.

Please consider participating in this important study by following the link:

www.Thissurvey.com/compass

If you need any further information, please contact our study coordinator Dr. Erik Wibowo at erik.w@dal.ca

We look forward to hearing from you.

 

 

Principal Investigator:

Tsz Kin (Bernard) Lee, MD, Radiation Oncology, British Columbia Cancer Agency, Abbotsford Cancer Centre

Contact Number: 1-877-547-3777; Email: Bernard.Lee@bccancer.bc.ca

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study. We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study. Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Tsz Kin Lee
18775473777
Bernard.Lee@bccancer.bc.ca
Wednesday, August 2, 2017 - 12:23pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Monday, March 19, 2018 - 12:15pm

Purpose: The American Cancer Society is testing a modified version of the Cancer Survivors Network (CSN) and is inviting you to try it. This research is being done in collaboration with Carnegie Mellon University and is sponsored by the National Institutes of Health.

 

Procedure: Your participation is voluntary.  If you agree, you will use a modified version of CSN to participate in the community.  You will have access to all CSN content, and any posts or comments you make will be added to the CSN community, just as they are now. What is new is that you will see recommendations for content and other members that might interest you. These recommendations are based on what you have read on CSN. As you read more discussion threads, the recommended content and members will be updated. You will occasionally receive a survey to get your feedback on the new interface. We will also ask about the relevance and value of the recommended content.   These surveys will take less than three minutes to complete, and you will receive them at most once per week. We will also invite a small number of members to give more extensive feedback through a phone interview.

 

To participate in this trial, click this link: Yes, I’ll use the new CSN interface.  You can always opt-out later by clicking ‘the use the traditional CSN design’ button on your CSN user profile.

 

Principal investigators:

Robert Kraut, PhD

Herbert A. Simon Professor of Human-Computer Interaction

Carnegie Mellon University

Pittsburgh PA 15213

412 268-7694

robert.kraut@cmu.edu

 

Tenbroeck Smith

Director of Patient Reported Outcomes Research, Behavioral Research Center

American Cancer Society

Atlanta GA

 

tenbroeck.smith@cancer.org

For more information, contact:
Robert Kraut
(412) 268-7694
robert.kraut@cmu.edu
Friday, July 28, 2017 - 8:27pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Wednesday, June 14, 2017 - 10:30am

The University of South Carolina College of Nursing, in partnership with the American Cancer Society’s Reach to Recovery® Program, is recruiting participants for a research study.

Are you a breast cancer survivor and want to become more physically active? Moving Forward Together 3, a home-based exercise research study, may be for you.

Please see study brochure below.

For questions and/or additional information about the study, call 1-888-829-1916 or email CHAPMAKP@mailbox.sc.edu or visit uof.sc/nursing-movingforward.

Participants do not have to live in South Carolina, but they must live in the Eastern time zone to participate.

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

 

 

For more information, contact:
Kimberly Bowyer
1-888-829-1916
CHAPMAKP@mailbox.sc.edu
Wednesday, February 24, 2016 - 11:17pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Wednesday, February 24, 2016 - 11:15pm

A study to bank blood and tissue samples for future evaluation to identify genetic mutations and other biomarkers that predispose inflammatory bowel disease (IBD) patients to developing Hepatosplenic T-Cell Lymphoma (HSTCL). Samples will be obtained from patients who have Crohn's Disease (CD) or Ulcerative Colitis (UC), who have been treated with adalimumab and diagnosed with HSTCL. 

Inclusion Criteria:

1. Male or female who has received a single dose of HUMIRA prior to a confirmed diagnosis of HSTCL.

2. Confirmed diagnosis of CD or UC as documented by a Gastroenterologist or physician who diagnosed the CD or UC.

3. Confirmed diagnosis of HSTCL as determined by a biopsy performed on a specimen taken from the patient.

4. Patients 18 years old and older must voluntarily sign and date an IRB/EC approved Informed Consent Form. For patients younger than 18 years old, a parent or legal guardian is required to voluntarily sign and date an IRB/EC approved Informed Consent Form. Pediatric patients will be included in all discussions if possible, in order to obtain their assent.

Exclusion Criteria:

1.  Male or female who has not received at least a single dose of adalimumab prior to a confirmed diagnosis of HSTCL.

2. Unconfirmed diagnosis of HSTCL, CD or UC, respectively.

3. The patient or the patient's HCP is unwilling to participate in this study. 

4. The parents or legal guardians (in the case of patients younger than 18 years of age), who are unable and/or unwilling to consent to the patient's participation in this study.

 

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contact provided below. 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Andrea Byars
847-937-7904
andrea.byars@abbvie.com

Pages